Dr. David C. Beyer spoke at the 23rd annual Perspectives in Urology Point • Counterpoint meeting on Friday, November 14, 2014 on “Updates in Radiation (Alpha, Beta, Gamma, Photon, Proton).”

 

Keywords: radiation (alpha, beta, gamma, photon, proton), prostate cancer

How to cite: Beyer, David C. “Updates in Radiation (Alpha, Beta, Gamma, Photon, Proton)” Grand Rounds in Urology. July 23, 2015. Accessed Dec 2024. https://dev.grandroundsinurology.com/prostate-cancer-david-c-beyer-updates-in-radiation/.

References

Efstathiou JA, Trofimov AV, Zietman AL. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer. Cancer J. 2009 Jul-Aug;15(4):312-8.
http://www.ncbi.nlm.nih.gov/pubmed/19672148

Fonteyne V, Soete G, Arcangeli S, et al. Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e483-90.
http://www.ncbi.nlm.nih.gov/pubmed/23243199

Kupelian PA, Willoughby TR, Reddy CA, et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1424-30.
http://www.ncbi.nlm.nih.gov/pubmed/17544601

Leborgne F, Fowler J. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1441-6.
http://www.ncbi.nlm.nih.gov/pubmed/19395194

Rusthoven CG, Carlson JA, Waxweiler TV, et al. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1064-73.
http://www.ncbi.nlm.nih.gov/pubmed/24661660

Swisher-McClure S, Pollack CE, Christodouleas JP, et al. Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):8-15.
http://www.ncbi.nlm.nih.gov/pubmed/22079721

Thames HD, Suit HD. Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):687-91.
http://www.ncbi.nlm.nih.gov/pubmed/3700173

Tward JD, Kokeny KE, Shrieve DC. Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival. Pract Radiat Oncol. 2013 Jul-Sep;3(3):234-40.
http://www.ncbi.nlm.nih.gov/pubmed/24674370

Yu JB, Soulos PR, Herrin J, et al. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst. 2013 Jan 2;105(1):25-32.
http://www.ncbi.nlm.nih.gov/pubmed/23243199

ABOUT THE AUTHOR

David C. Beyer, MD

Dr. Beyer is the Medical Director of Radiation Oncology at the Centers of Northern Arizona Healthcare in Sedona. He grew up in Phoenix and earned his medical degree from the University of Arizona College of Medicine after studying electrical engineering at the Massachusetts Institute of Technology in Boston. He completed consecutive residencies in both Internal Medicine and Radiation Oncology at the University of Arizona Health Sciences Center and the University of California, Los Angeles. He then went on to practice in Phoenix and Scottsdale from 1985-2014. He is board-certified in both Radiation Oncology and Internal Medicine.
While in private practice, he has published more than 40 peer reviewed articles on cancer treatments, guideline development, and health policy, with an emphasis on prostate cancer. He has advised Medicare on policy as a member of the MedCAC and has been actively involved in cancer care policy development throughout the past decade of healthcare reform.
Dr. Beyer has served as President for the American Society for Radiation Oncology, the American Brachytherapy Society, and the Arizona Radiologic Society. He has also served on the Council Steering Committee of the American College of Radiology and the Board of Chancellors for the American College of Radiation Oncology. He is a Governor-appointed member of the Arizona Medical Board.